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Abstract： 
The X-box binding protein 1 (XBP1) is a pivotal transcription factor in the endoplasmic 
reticulum stress response. Our previous studies have proven that XBP1 is involved in 
vascular endothelial growth factor (VEGF)-mediated endothelial cell (EC) proliferation and 
angiogenesis. In this study, we used EC monolayer wound healing, tube formation and 
transwell migration models to explorethe role of XBP1splicing in EC migration. We found 
that scratching on EC monolayer triggered XBP1splicing, which was attenuated by the 
presence of SU5416and LY294002, suggesting that VEGF signalling pathways may be 
involved. Over-expression of the spliced XBP1 (XBP1s) via Ad-XBP1sgene transfer 
increased while knockdown of IRE1αor XBP1by ShRNA lentivirus suppressed EC migration. 
Over-expression of XBP1s up-regulated the nitric oxide synthase 3 (NOS3)mRNA through 
the 3’UTR-mediated stabilization and increased eNOS protein translation. Further 
experiments demonstrated that miR-24 participated in the XBP1s-induced eNOSup-
regulation and EC migration.Further co-IP and immunofluorescence staining assays revealed 
that protein kinase B (Akt), eNOS andXBP1s form a complex, resulting inAkt and eNOS 
nucleus relocation.These results suggest that XBP1 splicing can regulate eNOSexpression and 
cellular location, leading to EC migration and therefore contributing to wound healing and 
angiogenesis.  
Introduction 
Cardiovascular diseaseis one of the leading causes of death worldwide. It is a 
multifactorial multi-steps disease, in which the endothelium injury is the initial step of the 
disease development. Endothelial cells(ECs) are key cellular components of the blood 
vessels, forming an intact mono-layered structure of vasculature that acts as a semi-
permeable barrier between body fluids and the tissues, which modulating vessel tone via 
nitric oxide production[1, 2]. Endothelium injury is usually caused by risk factors or 
mechanical forces-induced ECs apoptosis, leading to local permeability change and a serial 
of inflammatory reactions. The adjacent EC proliferation and migration towards the denuded 
area plays an important role in vascular injury repairsand prevention of cardiovascular 
disease development.  
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Endothelial nitric oxide synthase (eNOS)enzyme, encoded by the NOS3 gene, is one 
of the three isoforms that synthesize nitric oxide (NO). NO produced by eNOShave the 
ability topromote vascular relaxation,antioxidant and anti-thrombus, which is 
essentailtoregulating vascular tone, cellular proliferation, leukocyte adhesion, and platelet 
aggregation[3-5].As its attribution to NO production, eNOSplays an essential role in 
cardiovascular system protection[6]. 
MicroRNAs (or miRNAs) comprise a novel class of small, non-coding endogenous 
RNA molecules(about 22 nucleotides) that regulate gene expression by directing their target 
mRNAs for degradation or post-transcriptional regulation[7, 8]. MiR-24is conserved in 
various species, and belongs to miR-23~27~24 clusteron human chromosome 9 and 19. MiR-
24 has been shown to participate in regulation of vascular ECs proliferation, apoptosis, 
migration, inflammation and differentiation[9-11].  
The X-box binding protein 1 (XBP1) is a transcriptional factor containing a unique 
basic-region leucine zipper (bZIP) domain, which was originally identified as its capability of 
binding to the cis-acting X-box presented in the promoter regions of human major 
histocompatibility complex class II genes[12]. Accumulating evidence showed that XBP1, 
downstream of the inositol requiring enzyme 1 alpha (IRE1α), is a stress-inducible 
transcription factor that existson both invertebrate and vertebrate cells and is crucial for cell 
survival under stress conditions[13-15].In mammalian cells, XBP1 is a key signal transducer 
upon the endoplasmic reticulum (ER) stress response. XBP1 was reported to be associated 
with human disease such as metabolism disease, vascular disease and so on[16, 17].Although 
ER stress is reported to be participated in vascular diseases[18-22], the role of XBP1 in 
vascular disease and its relationshipto NO have not been well understood. In the current 
study, we demonstrated that EC monolayer injury via scratching induces XBP1 splicing, 
which in turn up-regulates and interacts with eNOS, leading to eNOS nuclear translocation 
that promotes EC migration. 
Results 
1. Wound in EC monolayer induced XBP1 splicing, whichwas involved in EC 
migration. 
XBP1 exists as unspliced (XBP1u) and spliced (XBP1s) forms via IRE1α-mediated 
unconventional splicing[15, 23]. TheXBP1 splicing was shown to be involved in EC 
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proliferation and apoptosis[24, 25]. To test whether XBP1 splicing is also involved in ECs 
migration, an endothelium damage model was mimicked in vitro by scratching a confluent 
human umbilical vein EC (HUVEC) monolayer, followed by the observation on cell 
migration and the assessment onXBP1s protein expression at 6h and 24h post-scratching. As 
shown is Figure 1A, the scratching activated XBP1 splicing as revealed by Western blot 
analysis. In order to verify whether the vascular endothelial growth factor (VEGF) signaling 
pathway was involved in the scratching-induced XBP1 splicing, selective inhibitors(SU1498, 
PD98059 or LY294002)were included.The quantitative RT-PCR with specific primer sets for 
XBP1u and XBP1s revealed that scratching decreased XBP1u but increased XBP1s mRNA 
levels, which was abolished by the inhibitors (Supplement 1).  These results suggest that 
endothelium damage activates XBP1 splicing in a VEGF signalling pathway dependent 
manner.   
 The endothelium damage normally triggers the adjacent ECs migration to the injured 
area. To assess whether the scratching-induced XBP1 mRNA splicing contributes to EC 
migration, the gain-of-function (via Adenoviral transfer of XBP1s) and loss-of-function (via 
shRNA lentivirus-mediated knockdown of XBP1 or IRE1α) assays were performed in 
HUVEC scratching model. As shown in Figure 1B, the over-expression of XBP1s enhanced 
EC migrationobserved at 8h post scratching.The effect of Ad-XBP1s is shown in Supplement 
1 B.As expected, the knockdown ofeither XBP1 or IRE1αattenuatedthe wound healing(Figure 
1C&1D). Further experiments with the tube formation on Matrigel assaysrevealed that 
knockdown of XBP1 or IRE1αsuppressed HUVECsbasal and VEGF-induced tube formation 
(Figure 1E). These results suggestXBP1 splicing indeed contributes to EC migration. 
2. Wound in EC monolayer up-regulated eNOS expression in an XBP1 splicing-
dependent manner. 
 Previous studies have shown that NO is a potent inducer of ER stress[26, 27], and 
eNOShas been shown to be involved in angiogenesis by supporting ECsmigration[28].Thus, 
we wondered whether there was a crosstalk between XBP1 splicing and eNOS in scratching-
induced wound healing. The eNOS protein levels and NO production were firstly detected 
following scratching of a confluent HUVEC monolayer. As shown in Figure 2A, eNOS 
protein level was dramatically increased at 6h post-injury and then gradually returned to the 
basal level as the incubation time proceeded. As expected, NO production ofthe culture 
medium was increased by scratching (Figure 2B). However, there is a time delay between 
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NO production andeNOS protein increase (Figure 2A versus Figure 2B). Further experiments 
revealed that the eNOS protein level increase might be due to NOS3 mRNA increase, which 
was VEGF signalling dependent (Figure 2C).We chose 3 different VEGF signalling pathway 
inhibitors.SU1498, is a selective inhibitor of the VEGFR2, having negligible activity at 
several other serine/threonine and tyrosine kinases[29].PD98059 is a potent and selective 
inhibitor of MAP kinase kinases (MAPKK), MEK1 and MEK2 by binding to the inactive 
form of MAPKK and prevents activation by upstream activators, whichcan be used to study 
the role of MAPKK signalling[30]LY294002 is a potent, cell permeable inhibitor of 
phosphatidylinositol 3-kinase (PI3K) that acts on the ATP binding site of the enzyme[31]. 
As described above, both XBP1 splicing and NOS3 expression were up-regulated by the 
scratching, there might be direct link between these two events. To test this, the XBP1 
expression and splicing were down-regulated via shRNA-mediated XBP1 and 
IRE1αknockdown respectively prior to the scratching experiments. As shown in Figure 2D 
and 2E, the scratching-induced up-regulation of NOS3 mRNA (Figure 2D) and eNOS protein 
(Figure 2E) was abolished by knockdown of either XBP1 or IRE1α. Further experiments with 
a tetracycline/doxycycline inducible system (Ad-TRE-XBP1s plus Ad-Tet-on) revealed that 
over-expression of XBP1s in HUVECs could increase eNOS protein level (Figure 2F) and 
NO production (Figure 2G). These results suggest that XBP1 splicing is sufficient and 
essential for endothelium damage-induced eNOSupregulation. 
3. XBP1s increased NOS3 mRNA stability via down-regulating microRNA miR-24. 
The upregulation of an mRNA molecule can be derived from an increase of its 
transcription or stability or both. As XBP1s is an intact transcription factor, the up-regulation 
of eNOS by XBP1s may be due to transcriptional regulation. To test this, the effect of XBP1s 
on the NOS3 promoter reporter expression (pGL3-NOS3-Luc reporter) was assessed. 
Surprisingly, overexpression of XBP1s significantly decreased the reporter geneexpression 
(Figure 3A). XBP1uand mature activating transcription factor 6 (ATF6N), another ER 
stresstransducer (28)exerted a slightlyinhibitory effecton NOS3promoter reporter 
expression(Figure 3A).These results imply that XBP1 splicing may increase NOS3 mRNA 
stability. It has been established that the 3’ untranslated region (3’UTR) plays an important 
role in mRNA stability. To test whether XBP1 splicing stabilises NOS3 mRNA through its 
3’UTR, the NOS3 mRNA 3’UTR was cloned into pSiCHECK2 reporter system. There are 
different NOS3 transcript variants with two types of 3’UTR, for which the transcript variants 
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tv1 and tv4 are the representatives. Both 3’UTRs (TV1-3’UTR and TV4-3’UTR) were cloned 
and their response to XBP1s was assessed in HUVECs. As shown in Figure 3B, over-
expression of XBP1s significantly increased the reporter gene expression, indicating that 
XBP1s can increase NOS3 mRNA stability. 
 microRNAs (miRNAs) are a group of short non-coding RNAs, capable of regulating 
mRNA stability via binding to mRNA 3’UTR. Through electronic analysis of the potential 
miRNA target sequences with the RNAwalk software, we found thathsa-miR-24, hsa-miR-
125andhsa-miR-214 possessed potential binding elements in both TV1- and TV4- 3’UTR. 
Quantitative RT-PCR analysis of these miRNAs following scratching revealed that all three 
miRNAs were dramatically down-regulated (Figure 3C). To test whether the down-regulation 
of these miRNAs was due to transcriptional suppression or increased degradation, exogenous 
miRNAmimics were introduced into HUVECs, followed by scratching and assessment of the 
miRNA levels. Compared to endogenous miRNAs, the transfection of exogenous miRNA 
mimics induced a huge accumulation of the miRNAs (Figure 3D). Interestingly, scratching of 
the ECs significantly decreased amount of exogenous miR-125 and miR-214, while had no 
effect on exogenous miR-24 (Figure 3D).Further experiments revealed that over-expression 
of XBP1s significantly decreased miR-24 level but had no effect on the other two miRNAs 
(Figure 3E). These results suggest that there are different mechanisms involved in the 
regulation of miR-24 and the other two miRNAs.  
As all three miRNAs have potential binding elements in NOS3 3’UTR and are down-
regulated by scratching, it is possible that their down-regulation contributes to NOS3 
stabilisation. To test this, exogenous miRNA mimics were introduced into ECs and subjected 
to scratching, followed by NOS3 mRNA analysis. As shown in Figure 3F, only the 
exogenous miR-24 mimics (premiR24) abolished scratching-induced NOS3 up-regulation, 
while the other two miRNAs had no effect. Similarly, only the exogenous miR-24 mimics but 
not the other two ablated XBP1s-induced eNOS protein (Figure 3G). These results suggest 
that the XBP1s-mediated down-regulation of miR-24 contributes to NOS3 mRNA and eNOS 
protein up-regulation.  
4. miR-24 attenuated XBP1s-induced EC migration 
To further explore whether the down-regulation of miR-24contributesECs 
migration,miR-24 mimics (premiR24) were introduced into HUVECs and infected with Ad-
XBP1s virus to over-express XBP1s, followed by EC migration assays with transwell and 
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wound healing models. As shown in Figure 4A and 4B, the XBP1s-induced EC migration 
was significantly attenuated by exogenous miR-24, suggesting that the down-regulation of 
miR-24 contributes to XBP1s-induced EC migration.   
5.eNOS was involved in EC migration via forming a complex with AKT and XBP1s. 
It has been reported that the eNOS/NO/Akt signalling pathway contributes to endothelium 
damage-induced EC migration[32, 33]. As described above, endothelium damage up-
regulates eNOS and NO production via XBP1ssplicing. Our previous study has demonstrated 
that XBP1s can activate Akt phosphorylation[25]. Thus, we wonder whether NO production 
and Akt activation contribute to XBP1s-induced EC migration. To test this, the eNOS 
inhibitor, NG-nitro-L-arginine methyl ester (L-NAME)[34], PI3K inhibitor LY294002 and 
PKG inhibitor KT5823were used to inhibit NO production and Akt activation, respectively. 
As shown in Figure 5A and supplement 2, LY294002 but not L-NAMEor KT5823abolished 
XBP1s-induced EC migration,suggesting that NO productionis not involved in XBP1s-
induced EC migration. However, knockdown of NOS3 by siRNA fully attenuated XBP1s-
induced EC migration (Figure 5B). As L-NAME is eNOS function(producing NO) inhibitor, 
not eNOS protein inhibitor, these results suggested that eNOS protein is essential for XBP1s-
induced EC migration.Immunoprecipitation assay pulled down XBP1s,Akt and eNOS 
togetherin XBP1s over-expressed cell (Figure 5C),indicating that these three proteins may 
form a complex. In order to identify the complex formation, VEGF stimulation was 
introduced and completed immunoprecipitation assay pulled down XBP1s, Akt and eNOS 
together(Supplement 3A).Furthermore,immunofluorescent staining revealed that Akt and 
eNOSwere relocated into the nucleus in the Ad-XBP1s infected cells(Fig. 5D), and the 
similar trend are detected in scratching and VEGF stimulated HUVECs(Supplement3B and 
3C).These results suggest that XBP1s, Aktand eNOS may form a complex in the nucleus. 
Discussion 
Endothelium damage is the initial step of the development of multiple cardiovascular 
diseases. The adjacent EC migration plays a key role in repairing the damaged endothelium. 
However, the underlying mechanisms are still unclear. In this study, we demonstrated that 
endothelium damage could activate XBP1 splicing in a VEGF signalling dependent manner, 
and that XBP1s not only regulated eNOS expression but also formed a complex with eNOS 
and Akt, which may contribute to endothelium damage-induced EC migration.  
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Endothelium damage in vivo usually induces platelet aggregation releasingplatelet-
derived growth factors and activates adjacent ECs secreting growth factors to increase the 
adjacent EC proliferation and migration in a paracrine and/or autocrine manner[35-38]. 
During this process, VEGF may play a vital role. Endogenous VEGF expression and its 
autocrine action could be regulated by other growth factors[39]. Our previous studieshave 
demonstrated that VEGF can activate XBP1 splicing through VEGF receptor 2, the kinase 
insert domain receptor(KDR) interaction with IRE1α[25]. In this study, we found that the 
wound-induced XBP1 splicing in HUVECs was blocked by KDR antagonist SU5416, 
suggesting that an active KDR signalling is essential. Several signalling pathways can be 
activated following KDR activation, of which the PI3K/Akt and MEK pathways are two 
serine/threonine kinase pathways[40]. However, the participation of these two signalling 
pathways in XBP1 splicing seems different in wound healing and VEGF stimulation. In this 
study, these two signalling pathways seemed involved in scratching-induced XBP1 splicing 
as the XBP1 splicing was blocked by either PD98059 (MEK inhibitor) or LY294002 
(PI3K/Akt inhibitor). However, both inhibitors had no effect on VEGF-induced XBP1 
splicing[25]. The discrepancy may reflect the fact that manygrowth factors can be secreted 
under scratching and there may be interaction among them. IRE1α is normally activated by 
autophosphorylation at Ser/Thr sites[41]. The involvement of the Ser/Thr kinase MEK or 
PI3K/Aktin XBP1 splicing suggests that these kinases may directly activate IRE1α 
phosphorylation, which needs detailed investigation. 
The eNOS expression andNO production play an essential role in the maintenance of 
vascular homeostasis[4, 42, 43].Dysfunction in eNOS activity may lead to endothelial 
dysfunction, which is associated with cardiovascular diseases such as hypertension and 
atherosclerosis[44].It has been reported that there is link between ER stress and NO 
production[45, 46].However, the direct crosstalk between eNOS and XBP1 splicing remains 
unknown. In this study, we demonstrated for the first time that XBP1s not only regulates 
NOS3 mRNA andeNOS protein expression and NO production but also physically interacts 
with eNOS. XBP1s increased NOS3 mRNA stability through down-regulating miR-24, which 
has a binding element in NOS3 mRNA 3’UTR and directs NOS3 mRNA degradation. The 
increased stability of NOS3 mRNA may activate a feedback transcriptional suppression of 
NOS3 gene, in which XBP1s is involved.  
eNOS protein is an enzyme with multiple functions. Coupling with co-factors, eNOS 
catalyses L-Arginine to produce NO, while under uncoupling conditions, eNOS produces 
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reactive oxide species[47, 48]. eNOS can also serve as a co-activator regulating gene 
transcription[49, 50]. In this study, we found that scratching of EC monolayer increased 
eNOS protein and NO production in an XBP1 splicing dependent manner, and that over-
expression of XBP1s increased eNOS protein and NO production. The delay of NO 
production following scratching-induced EC migration indicates that NO may play a less 
important role in EC migration, especially in XBP1s-induced EC migration. Indeed, the 
suppression of NO production via L-NAME had no effect on XBP1s-induced EC migration. 
Very importantly, in this study we found that XBP1s physically interacted with eNOS protein 
and Akt in the nucleus, suggesting that eNOS may act as co-activator or co-repressor of 
XBP1s and participate in gene transcriptional regulation. Further detailed investigation on 
identifying the target genes of the XBP1s/eNOS/Akt complex will surely extend the functions 
of both eNOS and XBP1.  
In summary, endothelium damage triggers the paracrine/autocrine secretion of growth 
factors from the adjacent ECs, which may include VEGF. The activation of VEGF receptor 
KDR and the downstream MEK and PI3K/Akt pathways contribute to IRE1α-mediated 
XBP1 splicing. The XBP1s down-regulates miR-24 transcription, which increases NOS3 
mRNA stability. The elevated NOS3 mRNA may drive XBP1s to supress NOS3 transcription 
via a feedback way on one hand, and increases eNOS protein level and NO production on the 
other hand. eNOS protein forms a complex with XBP1s and Akt, directing gene 
transcriptional regulation. The overall is to increase adjacent EC migration to repair damaged 
endothelium (Figure 6). This study adds new evidence on the role of XBP1 splicing in 
angiogenesis through up-regulating EC proliferation and migration.  
 
Experimental procedures 
Materials 
All cell culture serum and media were purchased from Gibico,while cell culture supplements were 
purchased from Sigma. Theantibody against Flag (ab190059) wasfrom Abcam. The antibodies against 
XBP1 (M-186,sc-7160), IRE1α (sc-20790),eNOS（sc-376542）, Akt1/2/3 (sc-81434) and GAPDH (sc-
25778) were fromSanta CruZ Biotech. All secondary antibodies werefrom Dakocytomation. All 
microRNA reagents were purchased from Thermo Fisher Scientific. SU1498, L-NAME, LY294002, KT-
5823, DMSO, DAPI, crystal violet and Nitrite/Nitrate Assay Kit (23479)were purchased from Sigma. 
Cell Culture 
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Human umbilical vein ECs (HUVECs, ATCC-PCS-100-010) were cultured on 0.04% gelatin-coated flasks 
in M199 medium supplemented with 1ng/ml β-EC growth factor, 3μg/ml EC Growth Supplement from 
bovine neural tissue, 10u/ml heparin, 1.25μg/ml thymidine, 10% FBS, 100u/ml penicillin and streptomycin 
in humidified incubator supplemented with 5% CO2. The cells were split every three daysat a ratio of 1:5.  
 
Adenoviral and shRNA lentiviral infection  
For adenoviral infection, HUVECs were incubated withAd-null, or Ad-XBP1u (unspliced XBP1) or Ad-
XBP1s (spliced XBP1) virus at 10 multiplicity of infection (MOI) for 6h, and then culturedin fresh 
complete growth medium for time duration indicated in figure legends. For the tetracycline inducible 
system, HUVECs were co-infected with Ad-TRE-XBP1s (10MOI) and Ad-Tet-on (2MOI) viruses for 6h 
and cultured for the time duration as indicated in figure legends. On the induction of XBP1s expression, 
1μg/ml doxycycline was added into the culture medium and incubated for time duration as indicated in the 
figure legends. For shRNA lentiviral infection,HUVECs were incubated with 100 transfection unit/cell of 
non-target shRNA or XBP1 shRNA or IRE1α shRNAlentivirus in the presence of 10mg/mL polybrene for 
16h, followed by culture in fresh complete growth mediumfor 72h and subjected to further treatments. 
Wound healing migration assay. 
Wound was created by scratching confluent HUVECs in 6-well plates with 1ml tip.After removal of the 
cell debris and medium, fresh M199 medium containing 0.5% FBS was added and incubated for 6 hr. For 
the observation of cell migration, threescratching lines were created in each of three wells. Images were 
taken with at three different sites on each scratching line at 0 hr and 6 hr. The average migrated cells 
werecalculated from 3 sites/line x 3 lines/well x3 wells. For the assessments on RNA or protein samples, 
10 (vertical) x 10 (horizontal) scratching lines were introduced into confluent HUVECs in ϕ100mm dishes.   
Trans-well migration assay 
The transfected and/or infected HUVECs were detached by using trypsin and resuspended in 
M199containing 0.5% FBS. A 100μl of 1 × 10
5
 cells/ml cell suspension was added into the insert and 600 
μ l of M199containing 0.5% FBS was added into the holder of the trans-well (8μm pore size), followed by 
incubation for 6 hr. The cells were then fixed with 4% paraformaldehyde (Sigma) for 15 minutes, and 
stained with crystal violet solution for 15 minutes. After removal of the cells inside theinsert, the migrated 
cells were observed under Nikon Eclipse TS100 microscope and images were taken byNikon Digital Sight 
system and processed with Adobe Photoshop software. Cells were calculated from 10 view/well x 3 wells 
using 10x or 20x lenses. 
Tube formation assay  
The tube formation assay was performed asdescribed previously[51]. Briefly, 100μl/well of growth factor-
reduced Matrigel solution (Millipore) was added to8-well chamber plate and solidified at 37 °C. 1 × 
10
5
shRNA lentivirus-infected HUVECs (72h) were resuspended in 100ul M199 medium supplemented 
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with 5μg/ml VEGF or 0.1% BSA and added tomatrigel containing wells in triplicate and incubated in 37 
°C humidified incubator supplemented with 5% CO2for 6h.Tube formation was observed under Nikon 
Eclipse TS100 microscope and images were taken byNikon Digital Sight system and processed with 
Adobe Photoshop software. Tube numbers were calculated from 10 view/well x 3 wells using 10x lenses. 
NO detection 
Scratching(3x3) was introduced into confluent HUVEC monolayer in 6-well plates. After removal of the 
cell debris, fresh M199 medium was added and incubated for time duration as indicated in the figure 
legends. The cell medium was collected and spun at 2000xg at 4ºCfor 5 minutes to remove cell debris. 
Eighty μl/wellof supernatant were added to 96-well platein triplicate and subjected to total NO [NO3- + 
NO2-] detection with Nitrite/Nitrate Assay Kit (Sigma) according to the protocol provided.  
MicroRNA analysis  
The cellular total RNA was isolated with mirVana™ miRNA isolation kit accordingto the manufacturer’s 
instruction. The reverse transcription of miRNAs was performed with the AppliedBiosystems® TaqMan® 
MicroRNA Reverse Transcription kit and Applied Biosystems® 5x RT primer. The quantitativePCR 
amplifications of samples were done via Applied Biosystems® TaqMan® Universal PCR Master Mix,No 
AmpErase® UNG and 20x TaqMan small RNA Assay with protocol provided. 
Pre-mir RNAs and siRNA transfection  
For transienttransfection assay, HUVECs were seeded in 6-well plates at 5 × 10
4
 cells/well in triplicate 24h 
prior totransfection and treated with serum and antibiotics free M199 medium 1h prior to transfection. 
Twentypmolof pre-miRRNAs were transfected into HUVECswith 9μl of lipofectamine RNAiMax 
(Thermo Fisher Scientific) according to the procedure provided. Six hourslater, the transfection solution 
was removed and fresh complete growth medium was added and the cells wereincubated and subjected to 
further treatment as indicated in the figure legends. For siRNA transfection assay, HUVECs were seeded 
in 25ml flasks 24h prior to transfection and treated with serum and antibiotics free M199 medium for 1h 
prior to transfection. Tenμl of 10μmol/L controlsiRNA or NOS3 siRNA (sc-36093)was transfected into 
HUVECs using 12μl of LipofectamineRNAimax (Invitrogen) according to the protocol provided. Fresh 
complete growth medium was added 6h post transfection and incubated for 48h. The cells were infected 
withAd-null orAd-XBP1s virus at 10MOIand incubatedfor 24 h, followed by trans-well migration assay.  
Luciferase Activity Assay 
HUVECs were seeded in 12-well plate at 5x10
4
cells/well 24h prior totransfection. HUVECs were 
transfected with (1) 0.1μg/well of pGL3-NOS3-Luc reporter and 0.02μg/wellof Renilla-Luc (internal 
control) together with 0.1μg/well of pShuttle2-XBP1s, pShuttle2-XBP1u or pShuttle2-ATF6N expression 
plasmids or (2) 0.1μg/well of psiCHECK2-TV1-3UTR or psiCHECK2-TV4-3UTRreportertogether with 
0.1μg/well of pShuttle2-XBP1sand incubated for 36h, followed by luciferase activity assay.pShuttle2 
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plasmid was included as vector control (Mock). The relative luciferase activity (RLA) was defined as the 
ratio of the reporter luciferase activity to the internal control luciferase activity with that of mock group set 
as 1.0.  
Immunoprecipitation and Immunoblotting 
Immunoprecipitation and immunoblotting were performed according to standard procedures described 
elsewhere. Briefly, the cells were lysed with IP-A buffer [10 mM Tris-HCl, pH7.5, 120 mMNaCl, 1 mML 
EDTA,1% Triton X-100 plus protease inhibitor cocktail tablets (one tablet for 50 mL, Roche)] and the 
protein concentrationwas measured by BioRad protein assay (BioRad)). One milligram lysate was mixed 
with 10µl of anti-FLAG-agarose beads (Sigma) and 3 volumes of IP-B buffer (IP-A buffer without Triton 
X-100) and incubated on a rotator at 4ºC for 4h, followed by SDS-PAGE and standard Western blot 
analysis. For the input control or routine Western blot, SDS-denatured 50μg lysate was applied to SDS-
PAGE. After transferring to PVDF membrane(Amersham), the target protein bands were detected with 
primary and secondary antibodies incubation, ECL development and X-ray filmexposure (Amersham). The 
images were processed by Adobe Photoshop software. 
RT-PCR and qPCR 
The total cellular RNA was extracted using Qiagen RNeasy Kit according to theprotocol provided. Two 
microgram RNA was transcribed into cDNA using Improm-IIreverse transcription system (Promega). For 
realtime PCR (qPCR), 20ng cDNA was amplified by a real time PCRSYBR master mix (Applied 
Biosystems). Primers for qPCR were designed with thePrimer Express Software (Applied Biosystems) as 
follows:XBP1u(forward) 5′-tgctgagtccgcagcactag-3′, XBP1s (forward) 5′-tgctgagtccgcagcaggtg-3′anda 
common reverse primer 5′-gctggcaggctctggggaag-3′;NOS35′- aggaacctgtgtgaccctca -3′and 5′ - 
cgaggtggtccgggtatcc -3′; β-actin 5’-cacaactgggacgacatggag-3’ and 5’-ttcatgaggtagtcagtctgg-3’ as internal 
control. 
 
Immunofluorescence staining  
The cells on slides were fixed with 4% paraformaldehyde at room temperature (RT) for 15min and 
permeabilised with 0.1% Triton X-100/PBS at RTfor 15min, followed by blocking with diluted normal 
serum (1:20) for 1h, incubationwith diluted primary and secondary antibodies at 37ºC for 1h and 45min, 
respectively. Nucleus was counterstained with DAPI. Images were taken by using SP5 confocalmicroscope 
(Leica, Germany) and processed by Adobe Photoshop software.  
 
Statistical Analysis 
Data expressed as the mean ± S.E. were analyzed using GraphPad Prism software (version 6) with t test for 
pair-wise comparisons or analysis of variance, when t test was inappropriate, followed by Dunnett's 
multiple comparison tests, and significance was depicted by asterisks (*, p < 0.05; **, p<0.01). 
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Figure 1. XBP1 splicing contributed to EC migration. (A) Wound induced XBP1 splicing. 
Wound was introduced into a confluent HUVEC monolayer by scratching, followed by 
observation of cell migration and western blot analysis of the spliced XBP1 (XBP1s) protein 
at 6h and 24h post-scratching. GAPDH was included as loading control. Scale bar: 100μm. 
(B) Over-expression of XBP1s enhanced EC wound healing. Confluent HUVECs were 
infected with Ad-null or Ad-XBP1s virus at 10 MOI for 24h, followed by scratching and 
observation of wound healing at time indicated. (C-E) Knockdown of XBP1 or 
IRE1αattenuated wound healing and tube formation.XBP1 splicing could be down-regulated 
by XBP1 shRNA (XBP1sh) or IRE1α shRNA (IRE1α) lentiviruses as revealed by Western 
blot (C). The lentivirus-infected HUVECs (for 72h) were subjected to wound healing assays 
(D) or tube formation on Matrigel assays in the absence or presence of 10ng/ml VEGF (E). 
Non-target shRNA (NTsh) lentivirus and 1% BSA were included as control. The relative 
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migrated area (RMA) was defined as the percentage of the area occupied by the migrated 
cells to that of the empty area created by the scratching. The data presented were 
representative images or average of three independent experiments. Scale bar: 100μm. 
*:p<0.05; **:p<0.01. 
 
 
Figure 2. Wound in EC monolayer up-regulated eNOS expression in an XBP1 splicing-
dependent manner. (A-B) Wound increased eNOS protein level (A) and NO production (B). 
Wound was introduced into a confluent HUVEC monolayer via scratching, followed by 
Western blot analysis of eNOS protein level (A) and NO production assay (B) at time 
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indicated post-scratching. (C) Inhibition of the VEGF signalling pathway abolished wound-
induced NOS3 expression. The confluent HUVEC monolayer was pre-treated with inhibitors 
for 1h, then subjected to scratching and incubation in the presence of inhibitors for 6hr, 
followed by quantitative RT-PCR analysis of NOS3 mRNAs. DMSO (DM) was included as 
vehicle control. SU: SU1498, PD: PD98059, LY: LY294002. (D) Knockdown of XBP1 or 
IRE1α abolished wound-induced NOS3 upregulation. HUVECs were infected with non-target 
(NTsh), XBP1 (XBP1sh) or IRE1α(IRE1αsh) shRNA lentivirus for 72h, followed by 
scratching and quantitative RT-PCR analysis of XBP1u, XBP1s and NOS3 mRNA levels at 
6h post-scratching. (F-G) Overexpression of XBP1s increased eNOS protein level and NO 
production. HUVECs were infected with Ad-TRE-XBP1s (10 MOI) together with Ad-Teton 
(2 MOI) for 24h, and then treated with 1ug/ml doxycycline (Dox) for time indicated, 
followed by Western blot analysis (F) and NO production assay (G). Ad-null was included as 
control. Anti-FLAG was included to indicate XBP1s expression. GAPDH was included as 
loading control. The data presented were representative images or average of three 
independent experiments. *: p<0.05. 
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Figure 3. XBP1s increased NOS3 mRNA stability via miR-24. (A) XBP1s suppressed 
pGL3-NOS3-Luc reporter expression. The relative luciferase activity (RLA) was defined as 
the ratio of firefly luciferase to renilla luciferase activity with that of mock group set as 1.0. 
(B) XBP1s increased pSiCHECK2-TV1-3’UTR and pSI-CHECK2-TV4-3’UTR reporter 
expression. The relative luciferase activity (RLA) was defined as the ratio of renilla luciferase 
to firefly luciferase activity with that of mock group set as 1.0. (C) Scratching down-
regulated miR-24, miR-125 and miR-214 in an XBP1 splicing dependent manner. 
Quantitative RT-PCR analysis of miR-24, miR-125, miR-214 levels was performed at 6h post 
scratching. (D) Scratching increased miR-125 and miR-214 degradation. PremiRs (pmir) 
were introduced into HUVECs and subjected to scratching, followed by quantitative analysis 
of the miRNAs levels. (E) Over-expression of XBP1s down-regulated miR-24. HUVECs 
were infected with Ad-XBP1s (10 MOI) for 24h, followed by quantitative RT-PCR analysis. 
(F) Exogenous premiR-24 (pmir24) abolished scratch-induced NOS3 mRNA upregulation. 
(G) Exogenous miR-24 abolished XBP1s-induced eNOS expression. HUVECs were 
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transfected with 10pmol/well premiR24, premiR125 and premiR214 respectively. 48h later, 
the transfected cells were infected with Ad-null or Ad-TRE-XBP1s/Ad-Teton virus at (10/2) 
MOI for 24h, and then treated with 1ug/ml doxycycline (Dox) for 1h, followed by Western 
blot analysis of eNOS and FLAG-tagged XBP1s expression. The data presented were 
representative images or average of three independent experiments. *: p<0.05. 
 
Figure 4. miR-24 was involved in XBP1s-induced ECs migration. HUVECs were 
transfected with premir24 for 6h, then infected with Ad-XBP1s (10 MOI) for 24h, followed 
by transwell migration assays (A) and wound healing assays (B). The relative migrated area 
(RMA) was defined as the percentage of the area occupied by the migrated cells to that of the 
empty area created by the scratching. Scale bar: 100μm. The data presented were 
representative images or average of three independent experiments. *: p<0.05. 
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Figure 5. eNOS was involved in EC migration via forming a complex with AKT and 
XBP1s. (A) LY294002 but not L-NAME abolished XBP1s-induced EC migration. HUVECs 
were infected with Ad-null or Ad-XBP1s virus at 10 MOI for 24h, then pretreat with 
LY294002 (5µmol/L) and L-NAME (100µmol/L) for 2h, followed by trans-well migration 
assay in the presence of inhibitors for 6h. Migrated cells were calculated using 20x lenses 
view. DMSO was included as vehicle control. Scale bar: 25µm. (B) Knockdown of 
NOS3abolished XBP1s-inducedECs migration. HUVECs were transfected with NOS3 
siRNAs for 48h, then infected with Ad-XBP1s for 24hr, followed by trans-well migration 
assay. Migrated cells were calculated using 10x lenses view. Control siRNA (ctlsi) and Ad-
null were included as control. Scale bar: 50µm.(C) XBP1s, eNOS and Akt formed a complex. 
anti-Flag antibody was used to pulldown and detect XBP1s. (D) XBP1s, eNOS and Akt co-
localised in the nucleus. Triple immunofluorescent staining was performed in Ad-null and 
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Ad-XBP1s infected HUVECs with anti-FLAG (green, for XBP1s), Akt (red), eNOS (purple). 
The nucleus was counter-stained with DAPI (blue). Scale bar: 10µm. The data presented 
were representative images or average of three independent experiments. *: p<0.05. 
 
Figure 6. The interaction between XBP1 and eNOS contributes endothelium damage-
induced EC migration.Endotheliumdamage activates VEGF receptor KDR in the adjacent 
ECs in a VEGF dependent or independent manner, which in turn activates IRE1α-mediated 
XBP1 mRNA unconventional splicing, removing a 26 nucleotide (nt) and causing the open 
reading frame to shift to produce a transcriptional active isoform, the XBP1s. XBP1s 
suppresses miR-24 transcription on one hand, leading to NOS3 mRNA stabilisation, eNOS 
protein and NO production increase. The elevated NOS3 mRNA may drive XBP1s 
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suppressing NOS3 transcription in a feed-back way. On the other hand, XBP1s may be 
involved in Akt activation and facilitate the nuclear relocation of Akt and eNOS protein to 
form an Akt/XBP1/eNOS complex in the nucleus, which may be involved in the transcription 
of genes that are involved in cell migration regulation. The overall effect is to increase the 
adjacent EC migration to repair the damaged endothelium. 
 
Supplement 1.Wound in EC monolayer induced XBP1 splicing in a VEGF signalling 
pathway dependent manner.VEGF signalling pathway inhibitors abolished the scratching-
induced XBP1 splicing. The confluent HUVEC monolayer was treated with inhibitors for 1h, 
then subjected to scratching and incubation in the presence of inhibitors for 6hr, followed by 
quantitative RT-PCR analysis of the unspliced (XBP1u) and spliced (XBP1s) XBP1 mRNAs. 
DMSO (DM) was included as vehicle control. SU: SU5416 (5µmol/L), PD: PD98059 
(5µmol/L), LY: LY294002 (5µmol/L). The data presented were representative images or 
average of three independent experiments. *: p<0.05. 
 
Interaction between XBP1 and eNOS 
 
25 
 
 
Supplement 2. XBP1 splicing induced endothelial cell migration is PKG 
independent.(A) HUVECs were infected with Ad-XBP1s (10 MOI) for 24h, followed by 
Western blot analysis. (B) Infected HUVECs then pretreat with KT-5823(5µmol/L for 2h, 
followed by trans-well migration assay in the presence of inhibitors for 6h. Migrated cells 
were calculated using 20x lenses view. DMSO was included as vehicle control. Scale bar: 
25µm. The data presented were representative images or average of three independent 
experiments. *: p<0.05. 
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Supplement 3：eNOS was involved in EC migration via forming a complex with AKT 
and XBP1s.(A)XBP1s, eNOS and Akt formed a complex with the treatment of VEGF. Anti- 
XBP1s antibody was used to pulldown. (B, C) XBP1s, eNOS and Akt co-localized in the 
nucleus. Triple immunofluorescent staining was performed in scratched (B) and VEGF(C) 
treated HUVECs with anti-Akt1/2 (red); anti-NOS3 (green), anti-XBP1s (gray). The nucleus 
was counter-stained with DAPI (blue). Scale bar: 10µm. The data presented were 
representative images or average of three independent experiments. *: p<0.05. 
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Abbreviations 
X-box binding protein 1 (XBP1) 
vascular endothelial growth factor (VEGF) 
endothelial cell (EC) 
XBP1 (XBP1s) 
nitric oxide synthase 3 (NOS3) 
adenovirus -XBP1s （Ad-XBP1s） 
Protein kinase B (Akt) 
nitric oxide synthase 3 (NOS3) 
nitric oxide (NO) 
basic-region leucine zipper (bZIP) 
inositol requiring enzyme 1 alpha (IRE1α) 
endoplasmic reticulum (ER) 
unsplicedXBP1 (XBP1u) 
human umbilical vein EC (HUVEC) 
NOS3 promoter reporter expression (pGL3-NOS3-Luc reporter) 
mature activating transcription factor 6 (ATF6N) 
NG-nitro-L-arginine methyl ester (L-NAME) 
the kinase insert domain receptor (KDR) 
doxycycline (Dox)\ 
Dimethyl sulfoxide (DMSO, DM) 
 
Highlights 
 Wound in EC monolayer induced XBP1 splicing, which was involved in EC migration. 
 XBP1s increased NOS3 mRNA stability via down-regulating microRNA miR-24. 
 ENOS was involved in EC migration via forming a complex with AKT and XBP1s. 
 
